British Patient Capital has invested £20 million in Cambridge Innovation Capital’s (CIC) second investment vehicle (CIC II). CIC was launched in 2013 and invests in deep-tech and life sciences businesses that have a connection with the Cambridge ecosystem.
The £20 million investment forms part of CIC II’s total fund size of £225 milion. The new fund will lead, or co-lead, investments in R&D intensive businesses across deep-tech and life sciences which have the potential to become global category leaders. They will predominantly be early-stage companies at their Series A round.
CIC II will invest in businesses with a link to Cambridge, either those with an operational presence in Cambridge, or a connection to the University of Cambridge via an IP license or a founder who has strong ties to the university.
